Chloe Botaine sat down with Ivan Kairatov, a Biopharma expert with deep R&D and tech experience, to discuss the European Commission’s approval of a long-acting monoclonal antibody for RSV prevention in newborns and infants. With a single intramuscular dose designed to protect for up to five months,
Hospitals feel the squeeze as drug-resistant infections outpace discovery, while conventional screening drains time and money without delivering medicines that dissolve, distribute, and survive the real world. That pressure has pushed researchers to reimagine how drugs are created, trading
A pediatrician opens a child’s electronic chart and scans years of well-visit notes, immunization stamps, brief school concerns, and sleep complaints, and in the space between those ordinary lines an algorithm quietly surfaces a pattern that suggests the child’s risk for
Admission to GLP-1 therapy once crawled through a maze of clinic calendars, phone tag, and insurer scripts, but a wave of purpose-built telehealth apps has turned that maze into a guided lane on a phone that now functions as both navigator and engine. The change was not merely cosmetic. Adaptive
Relentless rises in drug-resistant infections have turned routine care into a negotiation with risk that standard antibiotics too often lose, and the search for smarter countermeasures has shifted to tools built by biology itself. Bacterial extracellular vesicles (BEVs) sit at that inflection
Healthcare facilities across the United States are currently navigating an era of unprecedented digital transformation where the rapid retrieval of patient data is essential for emergency clinical decision-making. However, the convenience of using mobile tablets and smartphones at the bedside
The recent breakthrough in oncological research has shifted the paradigm from analyzing what a tumor is composed of to understanding exactly how its internal components are physically positioned. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified that the spatial
The warming of coastal waters along the Atlantic and Mediterranean has accelerated the proliferation of Vibrio bacteria, creating an urgent public health crisis that demands immediate scientific intervention. As these pathogens thrive in rising temperatures, traditional medical approaches find
The abrupt cessation of nearly eight hundred million dollars in federal support has forced a paradigm shift in how the pharmaceutical industry approaches pandemic preparedness and biotechnological research. The landscape of global health security is currently witnessing a high-stakes test of
The clinical landscape for treating human papillomavirus-related oropharyngeal cancer has reached a critical turning point as oncologists move away from standardized radiation protocols toward highly individualized medical strategies. For decades, the primary challenge in managing throat cancer has
